Assessment of a blood product

Challenge A life science venture capital fund was contemplating investing in advanced plasma product opportunities being developed by a biopharmaceutical company, and needed a reality check on the...
Learn More

Providing due diligence for an Alzheimer’s treatment

Challenge: Our client, a major pension fund, was considering an investment in a Phase III neuroscience company, which was developing a small molecule to provide symptomatic relief of Alzheimer’s...
Learn More

Preparing an expert review paper

Challenge A venture-backed biotech company developing a clinical stage asset for the treatment of early-stage cancer was populating a data room and preparing for negotiations with a major pharma...
Learn More

Regulatory affairs due diligence in EU

Challenge An established generics company looking to acquire the French rights of an existing product franchise needed to perform regulatory and clinical due diligence on the French dossier.
Learn More

Point of care diagnostics due diligence

Challenge A major European venture capital investor needed to analyze the business plan of a novel point-of-care diagnostics company.
Learn More

Development strategy and business support for an early-stage oncology company

Challenge After a seed investment, Evgen, a start-up biotech had built an IP portfolio in the field of glucosinolates, chemicals found in brassica vegetables, that are potent inducers of...
Learn More

Screening for rare disease licensing opportunities

Challenge Our client, a commercial stage biotech company focused on rare and ultra-rare diseases was seeking to build its pipeline of development products. Whilst it had an established business...
Learn More

Searching and assessing stem cell medicines

Challenge A listed North American firm needed support with the identification of early-stage in-licensing or acquisition opportunities in the highly competitive field of regenerative medicine....
Learn More

Providing search and assessment support for oncology projects

Challenge A listed North American company needed hands-on support with the identification, assessment and in-licensing of early-stage oncology assets.
Learn More

Searching for late stage therapeutics, devices and diagnostics acquisition targets in the US

Challenge A well-capitalized European pharma company needed on-the-ground support with a search for late stage therapeutics, devices and diagnostics acquisition opportunities in the US. Alacrita was...
Learn More

Scouting for early-stage oncology opportunities

Challenge A listed North American company needed support with the identification, assessment and in-licensing of early-stage oncology assets.
Learn More

Conducting IP due diligence

Challenge We have conducted multiple due diligence projects, below are three examples:
Learn More